FDA Inspection 676852 — CP Pharmaceuticals Limited
The FDA completed an inspection of CP Pharmaceuticals Limited on Jul 29, 2010 in Wrexham. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jul 29, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wrexham (United Kingdom)